Fran Schulz, Director at EDAP TMS SA (FOCL), bought 10,000 shares at $4.75 ($48K) on 2026-08-14, disclosed to the SEC on 2026-08-17.
Director Fran Schulz purchased $47,500 worth of EDAP TMS shares at $4.75, marking the largest insider purchase in the company's history, signaling confidence in the stock's trajectory. This significant buy comes as the company reports strong Q2 2026 earnings with HIFU revenue surging 39%.
The stock is trading at a forward P/E of -7.50, indicating a negative earnings multiple, and recently surged 6.2% on August 5, 2026, following Q2 earnings results.
1) Q2 2026 earnings call on August 14, 2026, highlighting HIFU revenue growth of 39%; 2) Analyst price target revision to US$8.50 on July 19, 2026, up from US$6.83; 3) The largest insider purchase in company history on August 14, 2026.
The stock is trading at a forward P/E of -7.50, indicating a negative earnings multiple, which may reflect concerns about profitability or future earnings expectations.
Something here stands out, but not much.